Home/Filings/4/0001140361-22-000300
4//SEC Filing

Pennington James 4

Accession 0001140361-22-000300

CIK 0001604191other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 9:07 PM ET

Size

5.3 KB

Accession

0001140361-22-000300

Insider Transaction Report

Form 4
Period: 2022-01-03
Pennington James
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Stock option (right to buy)

    2022-01-03+7,5007,500 total
    Exercise: $1.45Exp: 2032-01-03Common stock, par value $0.0001 per share (7,500 underlying)
Footnotes (1)
  • [F1]The stock option vests in 36 equal monthly installments over a term of three (3) years beginning on the date of grant, conditioned on Mr. Pennington's continued employment by First Wave BioPharma, Inc. on the applicable vesting date.

Issuer

First Wave BioPharma, Inc.

CIK 0001604191

Entity typeother

Related Parties

1
  • filerCIK 0001668704

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 9:07 PM ET
Size
5.3 KB